An integrated computational workflow was applied to identify potential inhibitors of dengue virus RNA-dependent RNA polymerase (RdRp) after screening of approximately 9,900 bioactive compounds through structure-based virtual screening and molecular docking, supporting these compounds as promising RdRp inhibitors.
Abstract
ABSTRACT An integrated computational workflow was applied to identify potential inhibitors of dengue virus RNA-dependent RNA polymerase (RdRp) after screening of approximately 9,900 bioactive compounds through structure-based virtual screening and molecular docking. Promising hits were further evaluated using density functional theory (DFT), molecular dynamics (MD) simulations, MM/GBSA free energy calculations, principal component analysis (PCA), free energy landscape (FEL) analysis, machine learning – based QSAR, and ADMET profiling. Redocking highlighted F2924-0102, F3299-0084, and F1411-0380 as top candidates, with docking scores of −12.6, −9.7, and −9.1 kcal/mol, respectively, comparable to the reference inhibitor 68 T (−8.6 kcal/mol). Replicated 500 ns MD simulations demonstrated stable conformations with consistent RMSD, RMSF, radius of gyration (RoG), and solvent-accessible surface area (SASA), indicating system stability and convergence. MM/GBSA analysis revealed favourable binding free energies, particularly for F1411-0380 (−64.02 ± 4.94 kcal/mol) and F2924-0102 (−57.73 ± 4.36 kcal/mol), primarily driven by van der Waals and hydrophobic interactions. Energy decomposition confirmed stable binding to catalytic residues. PCA and FEL analyses identified F2924-0102 as the most stable complex. QSAR predicted pIC50 values between 7.110 and 7.279, while ADMET results indicated good pharmacokinetic properties, supporting these compounds as promising RdRp inhibitors.
A protein-protein interaction network from the genes associated with the dengue infection was constructed and proteins were ranked by the topological centrality to identify hub regulators and validated POLR2A and ELOC as hub genes in the transcriptional regulation network associated with dengue.
S. M. Zaidh, M. H. Mohamed Asrarullah, Kathiravan Muthukumaradoss et al.· Journal of Pharmaceutical In...· 0 citations
The findings suggest that Lig-1, followed by Lig-3, may serve as promising computational lead compounds targeting SARS-CoV-2 MPro, representing promising candidates for further experimental validation.
Mohd Yasir Khan, Farah Maarfi, A. Shah et al.· International Journal of Mol...· 0 citations
Docking analysis identified two lead compounds that favorably occupied the catalytic pocket and formed stabilizing interactions with key residues, including His40, Glu71, and Cys147, in comparison with the reference inhibitor rupintrivir as promising non-covalent HRV 3Cpro inhibitor candidates for further experimental...
This work establishes AI‑driven structure prediction as a useful tool for identifying preliminary binding compounds for monkeypox virus infection, and provides a framework for rapid drug screening against emerging viral threats.
Tao Tao, Li Jia, Yu-Hang Cheng et al.· Journal of Computer-Aided Mo...· 0 citations
The conserved hydrophobic pocket at the dimer interface of the dengue capsid protein is explored as a novel target for antiviral intervention and repurposing of small molecules as anti-dengue therapeutics is proposed.
Dwaipayan Chaudhuri, K. Giri· In Silico Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.